2/2
© Reuters. FILE PHOTO: A sign marks the Novartis Institutes for BioMedical Research facility in Cambridge, Massachusetts, U.S., June 16, 2021. REUTERS/Brian Snyder/FILE PHOTO
2/2
NEW YORK (Reuters) -A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron (NASDAQ:) Pharmaceuticals against Novartis (SIX:) related to prescription treatments to address a condition…
